Bausch Health Companies Inc. (NYSE:BHC) Q4 2023 Earnings Conference Call February 22, 2024 8:00 AM ET
Company Participants
Thomas Appio - Chief Executive Officer
John Barresi - Senior Vice President, Chief Financial Officer (interim)
Maria Likuris - Investor Relations
Conference Call Participants
Glen Santangelo - Jefferies
Schuyler van den Broek - Piper Sandler
James - Evercore ISI
Chi - Bank of America
Douglas Miehm - RBC Capital Markets
Michael Nedelcovych - TD Cowen
Operator
Greetings. Welcome to the Bausch Health fourth quarter and full year 2023 earnings call.
At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded.
I would now like to turn the conference over to your host, Maria Likuris [ph]. Please go ahead.
Maria Likuris
Good morning and welcome to Bausch Health’s fourth quarter 2023 earnings conference call. Participating in today’s call are Thomas Appio, Chief Executive Officer of Bausch Health, and John Barresi, interim Chief Financial Officer.
Before we begin, I’d like to remind you that our presentation today contains forward-looking information. We ask you to take a moment to read the forward-looking statements disclaimer at the beginning of the slides that accompany this presentation as it contains important information. Our actual results may vary materially from those expressed or implied in our forward-looking statements and you should not place undue reliance on any forward-looking statements. Please refer to our SEC filings and filings with the Canadian securities administrators for a list of some of the risk factors that could cause our actual results to differ materially from our expectations.
We use non-GAAP financial measures to help investors understand our ongoing business performance. Non-GAAP financial measures may not be comparable to similarly titled measures used by other companies and should be considered along with but not as an alternative to measures calculated in accordance with GAAP. You will find reconciliations to our non-GAAP measures in the appendix of the slides that accompany this presentation, which are available on Bausch Health’s Investor Relations website.
Finally, the financial guidance in this presentation is effective as of today only. We do not undertake any obligation to update guidance. Our discussion today will focus on Bausch Health excluding Bausch & Lomb; however, we will briefly comment on Bausch & Lomb’s results announced yesterday. We will refer to year-over-year comparisons with the same period last year unless otherwise noted.